This study evaluates the analytical performance of the Elecsys PIVKA-II immunoassay to aid in HCC diagnosis, establish method-specific reference ranges in healthy individuals, and perform a method comparison versus commercially available platforms under routine laboratory conditions.
Chan HLY, Vogel A, Berg T, De Toni EN, Kudo M, Trojan J, Weinmann A, Eiblmaier A, Klein HG, Hegel JK, Morgenstern D, Madin K, Rolny V, Lisy MR, Piratvisuth T…
Cancer Type: Liver
Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC)
![Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC) Analytical performance and method comparison of the Elecsys PIVKA II immunoassay as an aid in diagnosis of hepatocellular carcinoma HCC Analytical performance and method comparison of the Elecsys PIVKA II immunoassay as an aid in diagnosis of hepatocellular carcinoma HCC](https://clinicalvalue.com/wp-content/uploads/2022/12/Analytical-performance-and-method-comparison-of-the-Elecsys-PIVKA-II-immunoassay-as-an-aid-in-diagnosis-of-hepatocellular-carcinoma-HCC.jpg)
A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort
![A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early stage hepatocellular carcinoma in an international cohort A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early stage hepatocellular carcinoma in an international cohort](https://clinicalvalue.com/wp-content/uploads/2022/12/A-comparative-analysis-of-Elecsys-GALAD-and-Elecsys-GAAD-score-to-detect-early-stage-hepatocellular-carcinoma-in-an-international-cohort.jpg)
This study compared the clinical performance of the Elecsys GALAD (gender [sex], age, alpha-fetoprotein [AFP] Lens culinaris agglutinin-reactive fraction of AFP [AFP-L3] and protein-induced by vitamin K absence-II [PIVKA-II]) and Elecsys GAAD (gender [sex], age, AFP and PIVKA-II) algorithms in differentiating hepatocellular carcinoma and benign chronic liver disease.
Chan HLY, Vogel A, Berg T, De Toni EN, Kudo M, Trojan J, Malinowsky K, Findeisen P, Klein HG, Hegel JK, Schöning W, Kröniger K, Madin K, Sharma A, Piratvisuth T
…
My greatest hope | Mr Yan’s liver cancer story
![My greatest hope | Mr Yan’s liver cancer story Patient Stories videos copy Mr Yan, a liver cancer patient, sitting down for an interview to tell his story about being unexpectedly diagnosed with HCC.](https://clinicalvalue.com/wp-content/uploads/2022/12/Patient-Stories-videos-copy.jpg)
Mr Yan was diagnosed with hepatocellular carcinoma (HCC) in 2018. He was a healthy, active person as a competitive skier, and his diagnosis was completely unexpected. With the support and love of his wife and son, Mr Yan has been able to remain hopeful. Hear his story here….
Hepatocellular carcinoma – the ‘silent killer’ disease infographic
![Hepatocellular carcinoma - the ‘silent killer’ disease infographic Liver disease infographic Liver disease infographic](https://clinicalvalue.com/wp-content/uploads/Liver-disease-infographic.jpg)
Chronic liver disease (CLD) is on the rise. CLD can progress to Hepatocellular Carcinoma (HCC), a type of liver cancer. What are the risk factors for HCC, and how is it diagnosed and treated? Read this infographic to find out more. …
Hepatocellular carcinoma – the ‘silent killer’ | Part 2
![Hepatocellular carcinoma – the ‘silent killer’ | Part 2 Hepatocellular carcinoma – the ‘silent killer Part 2 Hepatocellular carcinoma – the ‘silent killer Part 2](https://clinicalvalue.com/wp-content/uploads/Hepatocellular-carcinoma-–-the-‘silent-killer-_-Part-2.png)
How did Taiwan halve the incidence of hepatocellular carcinoma (HCC) in a decade? HCC is the primary form of liver cancer, with 72% of cases diagnosed in Asia. Find out about the challenges people with HCC face, and what can be done to improve outcomes….
Hepatocellular carcinoma – the ‘silent killer’ | Part 1
![Hepatocellular carcinoma – the ‘silent killer’ | Part 1 Hepatocellular carcinoma – the ‘silent killer Part 1 A busy shopping street filled with locals and tourists, holding shopping bags in their hands.](https://clinicalvalue.com/wp-content/uploads/Hepatocellular-carcinoma-–-the-‘silent-killer-_-Part-1.png)
Do you know what can cause hepatocellular carcinoma, the primary form of liver cancer? In Asia, contaminated food has historically been linked with the disease and hepatitis B and C continue to be a major risk factor. Find out more about these risk factors and others that are linked with liver cancer….